| Date |
Title |
Category |
|
| 28/02/2006 | Women 'more at risk' after heart surgery | Industry related health news | Read More |
| 28/02/2006 | Angiotech to appeal loss of UK patent | Company product news | Read More |
| 28/02/2006 | GlaxoSmithKline sees EU approve first vaccine for rotavirus | Company product news | Read More |
| 28/02/2006 | Teva posts record full-year profits | Company financials | Read More |
| 28/02/2006 | Chiron and Baxter seal deal on bird flu vaccine with UK, files 'mock up' with EMEA | Company product news | Read More |
| 28/02/2006 | Roche expects sales above industry average, says CEO | Company financials | Read More |
| 28/02/2006 | Healthcare firms double private medical aid in two years | Industry related health news | Read More |
| 28/02/2006 | Bird flu continues global spread | Industry related health news | Read More |
| 28/02/2006 | Breakthrough in MRSA studies | Industry related health news | Read More |
| 27/02/2006 | Kyowa Hakko licenses Parkinson's treatment from Britannia Pharmaceuticals | Company product news | Read More |
| 27/02/2006 | Amgen's denosumab found to increase bone density | Company product news | Read More |
| 27/02/2006 | GlaxoSmithKline makes raft of R and D appointments | | Read More |
| 27/02/2006 | GlaxoSmithKline blocks generic Flixonase sales | Company product news | Read More |
| 27/02/2006 | Boehringer Ingelheim gets EU approval for restless leg syndrome treatment | Company product news | Read More |
| 27/02/2006 | Statins cut heart attack risk as 'first symptom' | Industry related health news | Read More |
| 27/02/2006 | Xenon gas trial success | Industry related health news | Read More |
| 27/02/2006 | Novartis receives approval letter for Paget's disease treatment | Company product news | Read More |
| 24/02/2006 | Shire Pharmaceuticals announces sales increase of 19 per cent | Company financials | Read More |
| 24/02/2006 | Sanofi Aventis profits up 25 per cent as CEO extends tenure | Company financials | Read More |
| 24/02/2006 | Actelion income up 44 per cent in 2005 | Company financials | Read More |
